U.S. market Closed. Opens in 1 day 10 hours 10 minutes

RMD | ResMed Inc. Stock Fundamentals

(Stock Exchange: NYSE)
Analyzing fundamentals for RMD we got that it has strong fundamentals where Valuation is considered to be slightly undervalued, Profitability is stunning wealthy, Growth is exceptionally good and Health is very strong.

Valuation (62%)

Company Industry
P/E Ratio (TTM) 31.31 48.25
PEG Ratio (TTM) 3.45 4.11
P/S Ratio (TTM) 7.25 13.19
P/B Ratio (TTM) 6.71 7.06
P/FCF Ratio (TTM) 25.86 213.01
Price to 5YR AVG Earnings Ratio 45.68 103.21
Price to 5YR AVG FCF Ratio 51.88 93.76

Profitability (85%)

Company Industry
ROA (TTM) 15.41% 6.54%
ROE (TTM) 23.22% 11.33%
Net Profit Margin (TTM) 23.15% 0.38%
ROIC 5YR AVG 23.80% 11.38%

Growth (87%)

4QTR AVG 3YR AVG 5YR AVG
EPS 10.76% 30.49% 23.90%
Revenue 6.50% 11.16% 12.49%
Net Income 10.72% 31.42% 24.63%
Cash Flow 6.52% 4.75% 42.76%

Health (74%)

Company Industry
Current Ratio (TTM) 2.92 3.20
Quick Ratio (TTM) 1.91 2.42
D/E Ratio (TTM) 0.13 0.51
Interest Coverage (TTM) 37.59 38.35
Piotroski F-Score 7 6
Altman Z-Score 12.92 25.54
LTL to 5YR AVG FCF 1.25 4.32
Shares Outstanding Growth 5YR AVG 0.54% 0.77%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙